Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014346
Filing Date
2024-11-05
Accepted
2024-11-05 09:08:43
Documents
70
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20240930x10q.htm   iXBRL 10-Q 2301002
2 EX-31.1 qure-20240930xex31d1.htm EX-31.1 15055
3 EX-31.2 qure-20240930xex31d2.htm EX-31.2 15064
4 EX-32.1 qure-20240930xex32d1.htm EX-32.1 14754
  Complete submission text file 0001558370-24-014346.txt   8416960

Data Files

Seq Description Document Type Size
5 EX-101.SCH qure-20240930.xsd EX-101.SCH 53844
6 EX-101.CAL qure-20240930_cal.xml EX-101.CAL 53228
7 EX-101.DEF qure-20240930_def.xml EX-101.DEF 276901
8 EX-101.LAB qure-20240930_lab.xml EX-101.LAB 500175
9 EX-101.PRE qure-20240930_pre.xml EX-101.PRE 398779
73 EXTRACTED XBRL INSTANCE DOCUMENT qure-20240930x10q_htm.xml XML 1309946
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 241425943
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)